As the world adjusts to a new reality set by the pandemic, scientists are racing for a COVID-19 cure or treatment as the virus continues to spread. However, those who have recovered from the illness might be a key to saving lives. 

COVID-19, the respiratory disease caused by the novel coronavirus, has no treatment and no vaccine, but antibodies from recovered patients could help current others who are fighting the deadly virus. This type of treatment was first used in the 1890s to treat diphtheria, a bacterial infection that impacts the throat and nose. 

The blood component that carries the antibodies, known as plasma, can be gathered as "convalescent plasma" and given to newly infected coronavirus patients. 

Donors must have tested positive for COVID-19 and must wait a certain period of time after they tested negative for the disease, or be symptom-free for at least 28 days if they didn’t get a follow-up test, before being able to donate plasma. 

The whole donation process takes up to 90 minutes, according to Reuters. The blood is drawn from a donor, who met the appropriate criteria and is run through a device to extract the plasma before the remaining blood returns to the donor. The plasma from a single donation reportedly could be used to help two to four patients. 

According to the Food and Drug Administration, convalescent plasma has been studied in other respiratory infection outbreaks before such as SARS in 2003, H1N1 influenza in 2009 to 2010, and MERS in 2012.

COVID-19 convalescent plasma is in clinical trials, but although the FDA points out it's promising, it has not yet been proven to be effective as a way to treat COVID-19. With that being said, doctors do believe the method is worth attempting.

SOURCES: 

Why U.S. hospitals see promise in plasma from new coronavirus patients - Reuters

Coronavirus Survivors Keep Up the Fight, Donate Blood Plasma to Others - The Wall Street Journal

What Is Plasma? - Stanford Children's Health

Recommendations for Investigational COVID-19 Convalescent Plasma - U.S. Food and Drug Administration

Red Cross urges Americans to donate blood to prevent shortage during coronavirus scare - TODAY

Share:
More In Science
Our Biological Connections With Plants; Mind-Controlled Bionic Hand
On this episode of Cheddar Innovates: Brightseed Co-Founder breaks down what plant bioactives are, and how they're using the latest technology to study human's biological connections with plants; Esper Bionics CEO breaks down how they re creating a mind-controlled bionic hand that guest smarter the more you use it; Cheddar gets a look at Curiosity Stream's 'Capturing A Black Hole In Our Milky Way.'
NOAA Predicts Busier-Than-Usual Hurricane Season
Hurricane climatologist Jill Trepanier joined Cheddar News to discuss NOAA's announced prediction for an above-normal hurricane season and what it might mean for people in the United States. "I think it's important that people who maybe haven't been used to having extreme weather events related to say tropical cycles and tropical systems, like thinking New Jersey, Northeastern seaboard, that area may get more action than they're used to in the past," she said.
Miga Health Raises $12 Million to Combat Heart Disease
Dr. Jarrad Aguirre, Co-Founder and CEO of Miga Health, joins Cheddar News' Closing Bell, where he says his company is looking to establish the future of heart health and points to how 80% of premature heart attacks and strokes are preventable.
Cooling the Earth; How Global Warming will Impact Real Estate
On this episode of Cheddar Reveals, David Keith, Professor of Applied Physics at the Harvard School of Engineering and Applied Sciences and Professor of Public Policy at the Harvard Kennedy School, and founder of Carbon Engineering outlines the viability of solar geoengineering as a solution to help reverse the effects of global warming; Lena Geraghty, Sustainability & Urban Innovation Director at National League of Cities, discusses which U.S. cities are safest from global warming and how the real estate market will be impacted from the effects of climate change; Cheddar gets a look at Curiosity Stream's 'Changing Ocean Asia.'
Artificially Cooling the Planet
David Keith, Professor of Applied Physics at the Harvard School of Engineering and Applied Sciences and Professor of Public Policy at the Harvard Kennedy School, and founder of Carbon Engineering joins Cheddar Reveals to outline the viability of solar geoengineering as a solution to help reverse the effects of global warming.
Global Warming's Effect on the Real Estate Market
Lena Geraghty, Sustainability & Urban Innovation Director at National League of Cities, joins Cheddar News to discuss which U.S. cities are safest from global warming and how the real estate market will be impacted from the effects of climate change.
What Spending 665 Days in Space Feels Like
Peggy Whitson, Director of Human Space Flight, Axiom Space, joins Cheddar Innovates to discuss Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space.
Living in Outer Space; A New-Age Twist on Millenia-Old Remedies
On this episode of Cheddar Innovates, Peggy Whitson, Director of Human Space Flight, Axiom Space, breaks down Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space; William Li and Danielle Chang, co-founders of The Hao Life, discuss how they're shaking up the $71 billion supplement industry by putting a modern spin on traditional natural Chinese remedies; Cheddar gets a look at Curiosity Stream's 'Sagrada Familia: Gaudi's Challenge.'
Load More